ArticleFrontiers in medicine2022

Serum IL-12p40: A novel biomarker for early prediction of minimal change disease relapse following glucocorticoids therapy.

Mengqiu Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.